Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zippelius

Showing results (191-200 of 308) with videos related to

Pageof 31
Sort By:
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Vaccine|December 13, 2002
Therapeutic cancer vaccines based on molecularly defined human tumor antigensPedro Romero, Mikael Pittet, Valerie Dutoit, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunityAbhishek S Kashyap, Tamara Thelemann, Richard Klar, et al.
European Journal of Immunology|September 1, 2005
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donorsSteffen Walter, Gilles Bioley, Hans-Jörg Bühring, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Science Signaling|September 19, 2019
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4<sup>+</sup> T cellsSarah Dimeloe, Patrick Gubser, Jordan Loeliger, et al.
Frontiers in Immunology|November 6, 2023
<sup>13</sup>C tracer analysis reveals the landscape of metabolic checkpoints in human CD8<sup>+</sup> T cell differentiation and exhaustionAlexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2008
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patientsAshley J Knights, Natko Nuber, Christopher W Thomson, et al.
Cellular & Molecular Immunology|March 6, 2024
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2Ronja Wieboldt, Michael Sandholzer, Emanuele Carlini, et al.
Pageof 31

Showing results (191-200 of 308) with videos related to

Sort By:
Pageof 31
Blood|May 17, 2003
Ex vivo characterization of human CD8+ T subsets with distinct replicative history and partial effector functionsNathalie Rufer, Alfred Zippelius, Pascal Batard, et al.
Vaccine|December 13, 2002
Therapeutic cancer vaccines based on molecularly defined human tumor antigensPedro Romero, Mikael Pittet, Valerie Dutoit, et al.
Journal for Immunotherapy of Cancer|March 16, 2019
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunityAbhishek S Kashyap, Tamara Thelemann, Richard Klar, et al.
European Journal of Immunology|September 1, 2005
High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donorsSteffen Walter, Gilles Bioley, Hans-Jörg Bühring, et al.
Clinical Lung Cancer|May 29, 2012
Carboplatin and paclitaxel plus ASA404 as first-line chemotherapy for extensive-stage small-cell lung cancer: a multicenter single arm phase II trial (SAKK 15/08)Martin Früh, Richard Cathomas, Marco Siano, et al.
Science Signaling|September 19, 2019
Tumor-derived TGF-β inhibits mitochondrial respiration to suppress IFN-γ production by human CD4<sup>+</sup> T cellsSarah Dimeloe, Patrick Gubser, Jordan Loeliger, et al.
Frontiers in Immunology|November 6, 2023
<sup>13</sup>C tracer analysis reveals the landscape of metabolic checkpoints in human CD8<sup>+</sup> T cell differentiation and exhaustionAlexander Kirchmair, Niloofar Nemati, Giorgia Lamberti, et al.
Swiss Medical Weekly|July 19, 2006
Clinical significance of cyclooxygenase-2 (COX-2) in multiple myelomaA Trojan, M Tinguely, S Vallet, et al.
Cancer Immunology, Immunotherapy : CII|July 30, 2008
Modified tumour antigen-encoding mRNA facilitates the analysis of naturally occurring and vaccine-induced CD4 and CD8 T cells in cancer patientsAshley J Knights, Natko Nuber, Christopher W Thomson, et al.
Cellular & Molecular Immunology|March 6, 2024
Engagement of sialylated glycans with Siglec receptors on suppressive myeloid cells inhibits anticancer immunity via CCL2Ronja Wieboldt, Michael Sandholzer, Emanuele Carlini, et al.
Pageof 31